BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25474363)

  • 1. Structural and theoretical studies on rhodium and iridium complexes with 5-nitrosopyrimidines. Effects on the proteolytic regulatory enzymes of the renin-angiotensin system in human tumoral brain cells.
    Illán-Cabeza NA; Jiménez-Pulido SB; Ramírez-Expósito MJ; García-García AR; Peña-Ruiz T; Martínez-Martos JM; Moreno-Carretero MN
    J Inorg Biochem; 2015 Feb; 143():20-33. PubMed ID: 25474363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of palladium(II) complexes of 5-nitrosopyrimidines and interactions with the proteolytic regulatory enzymes of the renin-angiotensin system in tumoral brain cells.
    Illán-Cabeza NA; García-García AR; Martínez-Martos JM; Ramírez-Expósito MJ; Moreno-Carretero MN
    J Inorg Biochem; 2013 Sep; 126():118-27. PubMed ID: 23816624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver(I)/6-hydroxyiminolumazine compounds differently modify renin-angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells.
    Ramírez-Expósito MJ; Mayas-Torres MD; Carrera-González MP; Jiménez-Pulido SB; Illán-Cabeza NA; Sánchez-Sánchez P; Hueso-Ureña F; Martínez-Martos JM; Moreno-Carretero MN
    J Inorg Biochem; 2014 Sep; 138():56-63. PubMed ID: 24892514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Effects of Doxazosin on Renin-Angiotensin-System- Regulating Aminopeptidase Activities in Neuroblastoma and Glioma Tumoral Cells.
    Ramírez-Expósito MJ; Martínez-Martos JM
    CNS Neurol Disord Drug Targets; 2019; 18(1):29-36. PubMed ID: 30370863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal complexes with the ligand derived from 6-acetyl-1,3,7-trimethyllumazine and benzohydrazide. Molecular structures of two new Co(II) and Rh(III) complexes and analysis of in vitro antitumor activity.
    Jiménez-Pulido SB; Linares-Ordóñez FM; Martínez-Martos JM; Moreno-Carretero MN; Quirós-Olozábal M; Ramírez-Expósito MJ
    J Inorg Biochem; 2008 Aug; 102(8):1677-83. PubMed ID: 18538411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
    Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
    Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.
    Ruiz J; Rodríguez V; Cutillas N; Samper KG; Capdevila M; Palacios Ò; Espinosa A
    Dalton Trans; 2012 Nov; 41(41):12847-56. PubMed ID: 22983366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium, rhodium, osmium, and iridium complexes of osazones (osazones = bis-arylhydrazones of glyoxal): radical versus nonradical states.
    Patra SC; Weyhermüller T; Ghosh P
    Inorg Chem; 2014 Mar; 53(5):2427-40. PubMed ID: 24520917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(2'-Pyridyl)-4,6-diphenylphosphinine versus 2-(2'-pyridyl)-4,6-diphenylpyridine: synthesis, characterization, and reactivity of cationic Rh(III) and Ir(III) complexes based on aromatic phosphorus heterocycles.
    de Krom I; Broeckx LE; Lutz M; Müller C
    Chemistry; 2013 Mar; 19(11):3676-84. PubMed ID: 23361944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
    Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
    Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodium-103 NMR of [Rh(X)(PPh3)3] [X = Cl, N3, NCO, NCS, N(CN)2, NCBPh3, CNBPh3, CN] and derivatives containing CO, isocyanide, pyridine, H2 and O2. Ligand, solvent and temperature effects.
    Carlton L
    Magn Reson Chem; 2004 Sep; 42(9):760-8. PubMed ID: 15307058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes.
    Leung SK; Kwok KY; Zhang KY; Lo KK
    Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.
    Pettinari R; Marchetti F; Pettinari C; Condello F; Petrini A; Scopelliti R; Riedel T; Dyson PJ
    Dalton Trans; 2015 Dec; 44(47):20523-31. PubMed ID: 26548708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structural characterization, and ligand replacement reactions of gem-dithiolato-bridged rhodium and iridium complexes.
    Rivas AB; Gascón JM; Lahoz FJ; Balana AI; Pardey AJ; Oro LA; Pérez-Torrente JJ
    Inorg Chem; 2008 Jul; 47(13):6090-104. PubMed ID: 18507456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of ferrocene appended Ru(II), Rh(III) and Ir(III) dipyrrinato complexes with DNA/protein, molecular docking and antitumor activity.
    Paitandi RP; Gupta RK; Singh RS; Sharma G; Koch B; Pandey DS
    Eur J Med Chem; 2014 Sep; 84():17-29. PubMed ID: 25014746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.